Oncocontraception

Ashlesha Patel; Alicia Roston; Kelly Stempinski; Lindsay Zimmerman; Erica O’Neill; Ashok R. Patel

doi:10.1007/978-1-4939-1233-9_14

Oncocontraception

Ashlesha Patel^*, Alicia Roston, Kelly Stempinski, Lindsay Zimmerman, Erica O’Neill, Ashok R. Patel

^*Corresponding author for this work

Obstetrics and Gynecology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

2 Scopus citations

Abstract

Over 700,000 women in the United States are diagnosed with cancer each year. Nearly 17 % of women with cancer are within the reproductive age. With improvements in treatments and prognosis, quality of life factors are increasing in importance for these women. Reproductive health is an important quality of life indicator. Focus on oncofertility has overshadowed other aspects of reproductive health including sexuality and oncocontraception. In this chapter we focus on the multiple facets of oncocontraception. While cancer treatments may alter fertility significantly, in the absence of reliable markers of fertility, contraception is paramount to reduce the risk of an unintended pregnancy. Cancer survivors are less likely to be offered effective contraception, if offered at all. Models of conceptualizing contraception are outlined as well as strategies to implement oncocontraception within oncologic care.

Original language	English (US)
Title of host publication	Contraception for the Medically Challenging Patient
Publisher	Springer New York
Pages	255-271
Number of pages	17
ISBN (Electronic)	9781493912339
ISBN (Print)	9781493912322
DOIs	https://doi.org/10.1007/978-1-4939-1233-9_14
State	Published - Jan 1 2014

ASJC Scopus subject areas

General Health Professions
General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-1-4939-1233-9_14

Cite this

@inbook{3f4507d1aaef4b46a73e020ecdcfc11c,

title = "Oncocontraception",

abstract = "Over 700,000 women in the United States are diagnosed with cancer each year. Nearly 17 % of women with cancer are within the reproductive age. With improvements in treatments and prognosis, quality of life factors are increasing in importance for these women. Reproductive health is an important quality of life indicator. Focus on oncofertility has overshadowed other aspects of reproductive health including sexuality and oncocontraception. In this chapter we focus on the multiple facets of oncocontraception. While cancer treatments may alter fertility significantly, in the absence of reliable markers of fertility, contraception is paramount to reduce the risk of an unintended pregnancy. Cancer survivors are less likely to be offered effective contraception, if offered at all. Models of conceptualizing contraception are outlined as well as strategies to implement oncocontraception within oncologic care.",

author = "Ashlesha Patel and Alicia Roston and Kelly Stempinski and Lindsay Zimmerman and Erica O{\textquoteright}Neill and Patel, {Ashok R.}",

note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media New York 2014.",

year = "2014",

month = jan,

day = "1",

doi = "10.1007/978-1-4939-1233-9_14",

language = "English (US)",

isbn = "9781493912322",

pages = "255--271",

booktitle = "Contraception for the Medically Challenging Patient",

publisher = "Springer New York",

}

TY - CHAP

T1 - Oncocontraception

AU - Patel, Ashlesha

AU - Roston, Alicia

AU - Stempinski, Kelly

AU - Zimmerman, Lindsay

AU - O’Neill, Erica

AU - Patel, Ashok R.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Over 700,000 women in the United States are diagnosed with cancer each year. Nearly 17 % of women with cancer are within the reproductive age. With improvements in treatments and prognosis, quality of life factors are increasing in importance for these women. Reproductive health is an important quality of life indicator. Focus on oncofertility has overshadowed other aspects of reproductive health including sexuality and oncocontraception. In this chapter we focus on the multiple facets of oncocontraception. While cancer treatments may alter fertility significantly, in the absence of reliable markers of fertility, contraception is paramount to reduce the risk of an unintended pregnancy. Cancer survivors are less likely to be offered effective contraception, if offered at all. Models of conceptualizing contraception are outlined as well as strategies to implement oncocontraception within oncologic care.

AB - Over 700,000 women in the United States are diagnosed with cancer each year. Nearly 17 % of women with cancer are within the reproductive age. With improvements in treatments and prognosis, quality of life factors are increasing in importance for these women. Reproductive health is an important quality of life indicator. Focus on oncofertility has overshadowed other aspects of reproductive health including sexuality and oncocontraception. In this chapter we focus on the multiple facets of oncocontraception. While cancer treatments may alter fertility significantly, in the absence of reliable markers of fertility, contraception is paramount to reduce the risk of an unintended pregnancy. Cancer survivors are less likely to be offered effective contraception, if offered at all. Models of conceptualizing contraception are outlined as well as strategies to implement oncocontraception within oncologic care.

UR - http://www.scopus.com/inward/record.url?scp=84932197185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932197185&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-1233-9_14

DO - 10.1007/978-1-4939-1233-9_14

M3 - Chapter

AN - SCOPUS:84932197185

SN - 9781493912322

SP - 255

EP - 271

BT - Contraception for the Medically Challenging Patient

PB - Springer New York

ER -

Oncocontraception

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this